Literature DB >> 10067698

A historical and molecular phylogeny of BCG strains.

M A Behr1, P M Small.   

Abstract

Bacillus Calmette-Guérin (BCG) is the name given to a family of vaccines derived in 1921 by the in-vitro attenuation of Mycobacterium bovis. Subsequently, BCG seed lots were distributed globally, and both phenotypic and genotypic differences between strains have been described. As a step to understanding BCG diversity, we have reviewed the English and French historical record on 13 strains and DNA was extracted from these strains for restriction-fragment-length-polymorphism study. The written record suggests "early strains" obtained from the Pasteur Institute between 1924 and 1926 and "later strains" obtained after 1931. Molecular typing resulted in 3 clades, based on variability in IS6110-typing and the presence of mpt64 gene. With two exceptions, these clades correspond with strains obtained in 1924-26 (IS6110-2/mpt64+), 1926-31 (IS6110-1/mpt64+), and 1931 or later (IS6110-1/mpt64-) This analysis demonstrates that BCG has undergone genetic changes since 1921, consistent with ongoing in-vitro evolution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067698     DOI: 10.1016/s0264-410x(98)00277-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  68 in total

1.  Performance of the MGIT TBc identification test and meta-analysis of MPT64 assays for identification of the Mycobacterium tuberculosis complex in liquid culture.

Authors:  Andrew J Brent; Daisy Mugo; Robert Musyimi; Agnes Mutiso; Susan Morpeth; Michael Levin; J Anthony G Scott
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

2.  Mycobacterium bovis BCG-Russia clinical isolate with noncanonical spoligotyping profile.

Authors:  Igor Mokrousov; Anna Vyazovaya; Yulia Potapova; Boris Vishnevsky; Tatiana Otten; Olga Narvskaya
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

Review 3.  Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

4.  A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.

Authors:  Chelsea Carpenter; John Sidney; Ravi Kolla; Kaustuv Nayak; Helena Tomiyama; Claudia Tomiyama; Oscar A Padilla; Virginie Rozot; Syed F Ahamed; Carlos Ponte; Valeria Rolla; Paulo R Antas; Anmol Chandele; John Kenneth; Seetha Laxmi; Edward Makgotlho; Valentina Vanini; Giuseppe Ippolito; Alexandra S Kazanova; Alexander V Panteleev; Willem Hanekom; Harriet Mayanja-Kizza; David Lewinsohn; Mayuko Saito; M Juliana McElrath; W Henry Boom; Delia Goletti; Robert Gilman; Irina V Lyadova; Thomas J Scriba; Esper G Kallas; Kaja Murali-Krishna; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  Tuberculosis (Edinb)       Date:  2015-08-01       Impact factor: 3.131

5.  Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.

Authors:  Virginia Davids; Willem Hanekom; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory Hussey; Ronel Sheperd; Lesley Workman; Jorge Soler; Rose Ann Murray; Stanley R Ress; Gilla Kaplan
Journal:  Clin Vaccine Immunol       Date:  2006-12-20

6.  Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Authors:  Ana M Aguirre-Blanco; Pauline T Lukey; Jacqueline M Cliff; Hazel M Dockrell
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

7.  An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein.

Authors:  Ruiling Fu; Chun Wang; Chunwei Shi; Mengji Lu; Zhengming Fang; Jia Lu; Fang Wang; Xionglin Fan
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

8.  Mucosal vaccination against tuberculosis using inert bioparticles.

Authors:  Rajko Reljic; Laura Sibley; Jen-Min Huang; Ilaria Pepponi; Andreas Hoppe; Huynh A Hong; Simon M Cutting
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

Review 9.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

10.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.